CELLINK, a leading 3D bioprinter provider, announced the launch of BIO X6, a six-printhead bioprinting platform that enables users to combine more materials, cells and tools than any other system on ...

Cellink’s BIO X6, a six-printhead bioprinting platform, offers the capability to combine more materials, cells, and tools to enhance research applications across the bioprinting field. BIO X6, a ...

CELLINK has this week unveiled a new addition to their range of Bioprinters with the launch of the new BIO X printer which provides tissue engineers with both Pneumatic and syringe extrusion ...

STOCKHOLM, March 15, 2021 /PRNewswire/ -- CELLINK has announced the launch of the BIO MDX™ Series, the next generation of bioprinters designed for high-throughput biofabrication and precision 3D ...

CELLINK, focused on the development and commercialization of innovative bioprinting technologies and bioinks, announced today that the company will collaborate with AstraZeneca to provide advanced ...

If you were to pick one emerging technology with the potential to have a massive positive impact on humanity in the coming years, there’s a good chance you’d go with 3D bioprinting. The ability to use ...

The Center of Excellence in 3D bioprinting of Cellink at the Indian Institute of Science (IISc), Bengaluru is expected to advance regenerative medicine, tissue engineering and drug discovery. The ...

CELLINK has been granted a patent for a unique cellulose-based bioink technology enabling bioprinting of multiple cell types for cell culturing, tissue engineering and regenerative medicine ...

CELLINK has launched the next part of a multiphase bioink expansion. This phase includes the release of two new bioink series, the expansion of three existing bioink series, the release of a new ...

Collplant Biotechnologies Ltd. has signed a collaboration agreement with 3D bioprinting company Cellink AB for future commercial production of regenerative breast implants. Rehovot, Israel-based ...